Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys

Ronny Bruffaerts; Meredith G. Harris; Alan E. Kazdin; Daniel V. Vigo; Nancy A. Sampson; Wai Tat Chiu; Ali Al-Hamzawi; Jordi Alonso; Yasmin A. Altwaijri; Laura Andrade; Corina Benjet; Giovanni de Girolamo; Silvia Florescu; Josep Maria Haro; Chi-Yi Hu; Aimee Karam; Elie G. Karam; Viviane Kovess-Masfety; Sing Lee; John J. McGrath; Fernando Navarro-Mateu; Daisuke Nishi; Siobhan O'Neill; Jose Posada-Villa; Kate M. Scott; Margreet Ten Have; Yolanda Torres; Bogdan Wojtyniak; Miguel Xavier; Zahari Zarkov; Ronald C. Kessler; WHO World Mental Hlth Survey Colla

doi:10.1007/s00127-022-02249-3

Back

Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys

Journal article

Peer reviewed

Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys

Ronny Bruffaerts, Meredith G. Harris, Alan E. Kazdin, Daniel V. Vigo, Nancy A. Sampson, Wai Tat Chiu, Ali Al-Hamzawi, Jordi Alonso, Yasmin A. Altwaijri, Laura Andrade, …

SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, Vol.57(10), pp.2079-2095

01/10/2022

DOI: https://doi.org/10.1007/s00127-022-02249-3

Handle:

https://hdl.handle.net/10523/18234

Abstract

Life Sciences & Biomedicine

Psychiatry

Science & Technology

Purpose To investigate the prevalence and predictors of perceived helpfulness of treatment in persons with a history of DSM-IV social anxiety disorder (SAD), using a worldwide population-based sample. Methods The World Health Organization World Mental Health Surveys is a coordinated series of community epidemiological surveys of non-institutionalized adults; 27 surveys in 24 countries (16 in high-income; 11 in low/middle-income countries; N = 117,856) included people with a lifetime history of treated SAD. Results In respondents with lifetime SAD, approximately one in five ever obtained treatment. Among these (n = 1322), cumulative probability of receiving treatment they regarded as helpful after seeing up to seven professionals was 92.2%. However, only 30.2% persisted this long, resulting in 65.1% ever receiving treatment perceived as helpful. Perceiving treatment as helpful was more common in female respondents, those currently married, more highly educated, and treated in non-formal health-care settings. Persistence in seeking treatment for SAD was higher among those with shorter delays in seeking treatment, in those receiving medication from a mental health specialist, and those with more than two lifetime anxiety disorders. Conclusions The vast majority of individuals with SAD do not receive any treatment. Among those who do, the probability that people treated for SAD obtain treatment they consider helpful increases considerably if they persisted in help-seeking after earlier unhelpful treatments.

Metrics

11 Record Views

18 Times Cited - Web of Science

See more details

Details

Record Identifier: 9926494813201891
Title: Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys
Creators: Ronny Bruffaerts
Meredith G. Harris
Alan E. Kazdin
Daniel V. Vigo
Nancy A. Sampson
Wai Tat Chiu
Ali Al-Hamzawi
Jordi Alonso
Yasmin A. Altwaijri
Laura Andrade
Corina Benjet
Giovanni de Girolamo
Silvia Florescu
Josep Maria Haro
Chi-Yi Hu
Aimee Karam
Elie G. Karam
Viviane Kovess-Masfety
Sing Lee
John J. McGrath
Fernando Navarro-Mateu
Daisuke Nishi
Siobhan O'Neill
Jose Posada-Villa
Kate M. Scott
Margreet Ten Have
Yolanda Torres
Bogdan Wojtyniak
Miguel Xavier
Zahari Zarkov
Ronald C. Kessler
WHO World Mental Hlth Survey Colla
Publication Details: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, Vol.57(10), pp.2079-2095
Academic Unit: Psychological Medicine (DSM)
Publisher: Springer Nature
Grant note: National Center for Public Health Protection Algorithm National Institute of Health of the Ministry of Health of Peru Ministry of Social Protection Regional Health Authorities of Murcia (Consejeria de Sanidad y Politica Social) Substance Abuse and Mental Health Services Administration (SAMHSA); United States Department of Health & Human Services R03 TW006481-01 / National Institute of Health/Fogarty International Center; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC) Health Research Council; Health Research Council of New Zealand Lundbeck; Lundbeck Corporation Shenzhen Bureau of Health Fundacion para la Formacion e Investigacion Sanitarias (FFIS) of Murcia Glaxo Smith Kline; GlaxoSmithKline INPRFMDIES 4280 / National Institute of Psychiatry Ramon de la Fuente OmniPharma Health & Social Care Research & Development Division of the Public Health Agency Saudi Basic Industries Corporation (SABIC) CONACyT-G30544-H / National Council on Science and Technology 044708 / Robert Wood Johnson Foundation (RWJF) FIS 00/0028 / Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain; Instituto de Salud Carlos III Eli Lilly Servier 03/00204-3 / State of Sao Paulo Research Foundation (FAPESP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Ministry of Health Pfizer PL 0256 / Institute of Psychiatry and Neurology in Warsaw King Faisal Specialist Hospital and Research Center Ministry of Economy and Planning, General Authority for Statistics WHO (Lebanon); World Health Organization 307933/2019-9 / Brazilian Council for Scientific and Technological Development (CNPq); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) EU Commission; European Union (EU); European Commission Joint Research Centre Center for Excellence on Research in Mental Health (CES University) Norwegian Financial Mechanism SAF 2000-158-CE / Ministerio de Ciencia y Tecnologia, Spain; Spanish Government Champalimaud Foundation Alcohol Advisory Council European Economic Area Grants John W. Alden Trust 2017 SGR 452; 2014 SGR 748 / Generalitat de Catalunya King Abdulaziz City for Science and Technology (KACST) Lebanese Ministry of Public Health ISCIII/FEDER; Spanish Government Australian Government Department of Health and Ageing; Australian Government; Department of Health & Ageing Gulbenkian Foundation Ministry of Public Health United Nations Development Group Iraq Trust Fund (UNDG ITF) European Economic Area Financial Mechanism King Saud University CIBER CB06/02/0046; RETICS RD06/0011 REM-TAP / Instituto de Salud Carlos III; Spanish Government UPO Regional Health Authorities of Murcia (Servicio Murciano de Salud) Ministry of Health (Saudi Arabia) Polish Ministry of Health 2002-17270/13-5 / Argentinian Ministry of Health (Ministerio de Salud de la Nacion) National Institute of Drug Abuse (NIDA); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA) Pan American Health Organization (PAHO) Consejo Nacional de Ciencia y Tecnologia; Consejo Nacional de Ciencia y Tecnologia (CONACyT) Phenicia AstraZeneca Foundation for Science and Technology (FCT); Fundacao para a Ciencia e a Tecnologia (FCT) Generalitat de Catalunya H13-SHOGAI-023; H14-TOKUBETSU-026; H16-KOKORO-013; H25-SEISHIN-IPPAN-006 / Japan Ministry of Health, Labour and Welfare; Ministry of Health, Labour and Welfare, Japan Benta Eli Lilly Romania SRL; Eli Lilly Shenzhen Bureau of Science, Technology, and Information Novartis U01-MH60220 / National Institute of Mental Health (NIMH); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH) New Zealand Ministry of Health GlaxoSmithKline QLG5-1999-01042; SANCO 2004123; EAHC 20081308 / European Commission; European Union (EU); European Commission Joint Research Centre
Date published ; e-published: 01/10/2022
Language: English
Resource Type ; Subtype: Journal article

Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys

Abstract

Related links

Metrics

Details